N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists

Amy Hauck Newman, Jianjing Cao, Christina J. Bennett, Michael J. Robarge, Rebekah A. Freeman, Robert R. Luedtke

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences